- Home
- CLGN vs BOF Comparison
CLGN vs BOF Comparison
Compare CLGN & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- BOF
- Stock Information
- Founded
- CLGN 2004
- BOF 2017
- Country
- CLGN Israel
- BOF United States
- Employees
- CLGN N/A
- BOF N/A
- Industry
- CLGN Industrial Specialties
- BOF Packaged Foods
- Sector
- CLGN Health Care
- BOF Consumer Staples
- Exchange
- CLGN Nasdaq
- BOF Nasdaq
- Market Cap
- CLGN 33.8M
- BOF 27.6M
- IPO Year
- CLGN N/A
- BOF 2023
- Fundamental
- Price
- CLGN $2.66
- BOF $2.36
- Analyst Decision
- CLGN Strong Buy
- BOF
- Analyst Count
- CLGN 2
- BOF 0
- Target Price
- CLGN $11.50
- BOF N/A
- AVG Volume (30 Days)
- CLGN 30.5K
- BOF 69.9K
- Earning Date
- CLGN 08-20-2025
- BOF 11-13-2025
- Dividend Yield
- CLGN N/A
- BOF N/A
- EPS Growth
- CLGN N/A
- BOF N/A
- EPS
- CLGN N/A
- BOF N/A
- Revenue
- CLGN $2,402,000.00
- BOF $10,179,595.00
- Revenue This Year
- CLGN $1,617.28
- BOF N/A
- Revenue Next Year
- CLGN $83.54
- BOF N/A
- P/E Ratio
- CLGN N/A
- BOF N/A
- Revenue Growth
- CLGN 248.62
- BOF 95.18
- 52 Week Low
- CLGN $1.31
- BOF $1.31
- 52 Week High
- CLGN $5.00
- BOF $3.10
- Technical
- Relative Strength Index (RSI)
- CLGN 52.88
- BOF 59.16
- Support Level
- CLGN $2.38
- BOF $2.32
- Resistance Level
- CLGN $2.77
- BOF $2.20
- Average True Range (ATR)
- CLGN 0.18
- BOF 0.08
- MACD
- CLGN -0.02
- BOF 0.03
- Stochastic Oscillator
- CLGN 47.46
- BOF 90.77
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.